Randomized, crossover pharmacodynamic study comparing the effects of Zegerid (20 mg omeprazole/sodium bicarbonate) and Prilosec OTC [over the counter] (20 mg-equivalent omeprazole)

Trial Profile

Randomized, crossover pharmacodynamic study comparing the effects of Zegerid (20 mg omeprazole/sodium bicarbonate) and Prilosec OTC [over the counter] (20 mg-equivalent omeprazole)

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Omeprazole/sodium bicarbonate (Primary) ; Omeprazole; Sodium bicarbonate
  • Indications Erosive oesophagitis; Gastro-oesophageal reflux; Peptic ulcer
  • Focus Pharmacodynamics; Registrational
  • Sponsors Bayer; Schering-Plough
  • Most Recent Events

    • 05 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 02 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top